surmount-1 tirzepatide obesity nejm 2022 weight loss percent The New - SURMOUNT-1: In an RCT, adults with treated with weekly had major over 72 weeks. #ADA2022 https://nej.md/3mjAbvD Tirzepatide versus Semaglutide Once Weekly

Frequently Asked Questions about GLP-1s in Psychiatry Which GLP-1 medications can psychiatrists prescribe

it can be administered via IV, IM, or SubQ injection

I used to think, right, there was maybe a subset of patients that I would maybe avoid

Patients often notice softer, suppler skin as a byproduct of the therapys internal rejuvenation

On the flip side, you might find a gentle walk and getting some fresh air helps ease side effects

A real-world retrospective study of 175 patients reported average weight loss of 5.9% at 3 months (Ghusn 2022), suggesting that measurable changes are typically underway during the first 6 weeks of treatment